rs199953230

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_001365276.2(TNXB):​c.12530G>A​(p.Ser4177Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.067 ( 23 hom., cov: 12)
Exomes 𝑓: 0.063 ( 733 hom. )
Failed GnomAD Quality Control

Consequence

TNXB
NM_001365276.2 missense

Scores

1
16

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:1

Conservation

PhyloP100: 0.728

Publications

12 publications found
Variant links:
Genes affected
TNXB (HGNC:11976): (tenascin XB) This gene encodes a member of the tenascin family of extracellular matrix glycoproteins. The tenascins have anti-adhesive effects, as opposed to fibronectin which is adhesive. This protein is thought to function in matrix maturation during wound healing, and its deficiency has been associated with the connective tissue disorder Ehlers-Danlos syndrome. This gene localizes to the major histocompatibility complex (MHC) class III region on chromosome 6. It is one of four genes in this cluster which have been duplicated. The duplicated copy of this gene is incomplete and is a pseudogene which is transcribed but does not encode a protein. The structure of this gene is unusual in that it overlaps the CREBL1 and CYP21A2 genes at its 5' and 3' ends, respectively. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
CYP21A2 (HGNC:2600): (cytochrome P450 family 21 subfamily A member 2) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and hydroxylates steroids at the 21 position. Its activity is required for the synthesis of steroid hormones including cortisol and aldosterone. Mutations in this gene cause congenital adrenal hyperplasia. A related pseudogene is located near this gene; gene conversion events involving the functional gene and the pseudogene are thought to account for many cases of steroid 21-hydroxylase deficiency. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
CYP21A2 Gene-Disease associations (from GenCC):
  • classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Myriad Women’s Health, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine
  • classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, salt wasting form
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, simple virilizing form
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.001997441).
BP6
Variant 6-32041874-C-T is Benign according to our data. Variant chr6-32041874-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 190377.
BS2
High Homozygotes in GnomAdExome4 at 733 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TNXBNM_001365276.2 linkc.12530G>A p.Ser4177Asn missense_variant Exon 43 of 44 ENST00000644971.2 NP_001352205.1
CYP21A2NM_000500.9 linkc.*740C>T downstream_gene_variant ENST00000644719.2 NP_000491.4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TNXBENST00000644971.2 linkc.12530G>A p.Ser4177Asn missense_variant Exon 43 of 44 NM_001365276.2 ENSP00000496448.1
CYP21A2ENST00000644719.2 linkc.*740C>T downstream_gene_variant NM_000500.9 ENSP00000496625.1

Frequencies

GnomAD3 genomes
AF:
0.0672
AC:
5778
AN:
86018
Hom.:
23
Cov.:
12
show subpopulations
Gnomad AFR
AF:
0.124
Gnomad AMI
AF:
0.0690
Gnomad AMR
AF:
0.0635
Gnomad ASJ
AF:
0.0770
Gnomad EAS
AF:
0.0198
Gnomad SAS
AF:
0.0718
Gnomad FIN
AF:
0.0294
Gnomad MID
AF:
0.0265
Gnomad NFE
AF:
0.0503
Gnomad OTH
AF:
0.0685
GnomAD2 exomes
AF:
0.0653
AC:
6962
AN:
106564
AF XY:
0.0728
show subpopulations
Gnomad AFR exome
AF:
0.0565
Gnomad AMR exome
AF:
0.0388
Gnomad ASJ exome
AF:
0.135
Gnomad EAS exome
AF:
0.0144
Gnomad FIN exome
AF:
0.0760
Gnomad NFE exome
AF:
0.0587
Gnomad OTH exome
AF:
0.0680
GnomAD4 exome
AF:
0.0630
AC:
32038
AN:
508402
Hom.:
733
Cov.:
6
AF XY:
0.0664
AC XY:
17868
AN XY:
268916
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.130
AC:
1613
AN:
12388
American (AMR)
AF:
0.0596
AC:
1652
AN:
27716
Ashkenazi Jewish (ASJ)
AF:
0.101
AC:
1553
AN:
15390
East Asian (EAS)
AF:
0.00974
AC:
295
AN:
30294
South Asian (SAS)
AF:
0.102
AC:
5552
AN:
54404
European-Finnish (FIN)
AF:
0.0564
AC:
2149
AN:
38086
Middle Eastern (MID)
AF:
0.0714
AC:
147
AN:
2060
European-Non Finnish (NFE)
AF:
0.0578
AC:
17447
AN:
301746
Other (OTH)
AF:
0.0619
AC:
1630
AN:
26318
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.342
Heterozygous variant carriers
0
2008
4016
6023
8031
10039
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
350
700
1050
1400
1750
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.0672
AC:
5787
AN:
86100
Hom.:
23
Cov.:
12
AF XY:
0.0684
AC XY:
2787
AN XY:
40722
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.124
AC:
2459
AN:
19816
American (AMR)
AF:
0.0633
AC:
513
AN:
8106
Ashkenazi Jewish (ASJ)
AF:
0.0770
AC:
150
AN:
1948
East Asian (EAS)
AF:
0.0199
AC:
73
AN:
3668
South Asian (SAS)
AF:
0.0711
AC:
173
AN:
2434
European-Finnish (FIN)
AF:
0.0294
AC:
179
AN:
6086
Middle Eastern (MID)
AF:
0.0337
AC:
7
AN:
208
European-Non Finnish (NFE)
AF:
0.0503
AC:
2127
AN:
42272
Other (OTH)
AF:
0.0673
AC:
73
AN:
1084
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.328
Heterozygous variant carriers
0
363
726
1090
1453
1816
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
68
136
204
272
340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.106
Hom.:
64
ExAC
AF:
0.0764
AC:
2582

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Ehlers-Danlos syndrome due to tenascin-X deficiency Uncertain:1
Jan 01, 2015
Pediatric Services, National Institutes of Health, Clinical Center
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:research

- -

not provided Uncertain:1
Mar 12, 2024
Mayo Clinic Laboratories, Mayo Clinic
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

BP4_strong -

not specified Benign:1
Jun 25, 2015
Genomic Diagnostic Laboratory, Division of Genomic Diagnostics, Children's Hospital of Philadelphia
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.050
BayesDel_addAF
Benign
-0.23
T
BayesDel_noAF
Benign
-0.57
CADD
Benign
15
DANN
Benign
0.88
DEOGEN2
Benign
0.0021
.;.;.;.;T
Eigen
Benign
-0.81
Eigen_PC
Benign
-0.63
FATHMM_MKL
Benign
0.040
N
LIST_S2
Benign
0.018
.;T;T;T;T
MetaRNN
Benign
0.0020
T;T;T;T;T
MetaSVM
Benign
-1.0
T
PhyloP100
0.73
PrimateAI
Pathogenic
0.81
D
PROVEAN
Benign
1.8
.;.;N;N;.
REVEL
Benign
0.22
Sift
Benign
0.55
.;.;T;T;.
Sift4G
Benign
1.0
.;.;T;T;T
Vest4
0.060, 0.092
MPC
1.5
ClinPred
0.0059
T
GERP RS
4.7
Varity_R
0.061
gMVP
0.076
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs199953230; hg19: chr6-32009651; COSMIC: COSV64475162; COSMIC: COSV64475162; API